Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{180981,
        author = {Krushna Raghu Bharwad and Onkar Subhash khatode and NIKAM MOHAN SUNIL and Dnyandev Sudarshan Barhate and Aditya Sudhakar Bhalerao and Krushna Deepak Bodhai and Rushikesh Prakash Nirgude and Aniruddh Subhash Thorat},
        title = {A BRIEF INTRODUCTION TO THE PHARMACOVIGILANCE(PV)},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {1},
        pages = {2977-2986},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=180981},
        abstract = {Pharmacovigilance (PV) constitutes a critical domain for ensuring patient safety across all aspects of pharmaceutical administration, whether oral or injectable. India remains in the early developmental phases of this field; considerable progress and knowledge acquisition are still necessary within PV to guarantee the secure execution of related protocols and achieve effective implementation of safety measures. Information plays a central function in pharmacovigilance through its comprehensive processes of data acquisition, examination, and distribution to ensure maximal patient safety. Pharmacovigilance is fundamentally grounded in effective information systems that enable the gathering of adverse event notifications from healthcare practitioners, patients, and various stakeholders. The transformation of data repositories has emphasized incorporating electronic health records, wearable technology, and real-world evidence to strengthen both the intensity and scope of information accessible for scrutiny. Cutting-edge technologies, particularly artificial intelligence and machine learning, are revolutionizing pharmacovigilance by automating signal identification and predictive frameworks. These instruments are employed to navigate extensive datasets, recognizing potential safety issues and supporting regulatory determinations.This elucidates the necessity for pharmacovigilance within pharmaceutical corporations, detailing its procedural aspects, historical evolution across centuries, and contemporary standing nationally. India's pharmaceutical sector ranks third globally by volume, positioning the country as a significant hub for clinical research and pharmaceutical development. The implementation of national pharmacovigilance programs has considerably enhanced public consciousness regarding medication safety.},
        keywords = {Adverse drug reactions, Clinical trials,Drug safety,Drug efficacy,Drug monitoring,Pharmacovigilance, Phases},
        month = {June},
        }